Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders - 1st Edition - ISBN: 9780128165454

Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders

1st Edition

Editors: Benjamin Bonavida Lucia Morbidelli
Hardcover ISBN: 9780128165454
Imprint: Academic Press
Published Date: 4th February 2019
Page Count: 400
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders presents updated reviews on the chemistry, signalling, pre-clinical activities and clinical activities on the role of NO donors/inhibitors used alone in a variety of diseases and also in combination with other therapeutic agents. Both cancer and inflammatory diseases are the focus on which this book is developed.

The book discusses many examples of studies related to the application of novel therapeutic compounds that include a chemical and nitric oxide. Those studies have been shown to exert significant therapeutic activities against various cancers and various inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, allergies, and asthma, in which no current effective therapies exist.

Edited and written by internationally renowned experts in the field of novel therapeutics for cancer, this book is a valuable source for cancer researchers, medical scientists, clinicians, clinical pharmacologists, and graduate students.

Key Features

  • Provides the readers in each chapter with a clear overview of the recent findings and references as well as summaries, significant molecular pathways, and conclusions
  • Discusses new ideas proposed and makes suggestions for further investigations that will advance the field
  • Presents a general introductory chapter that covers overall the contributions in this field and a chapter that summarizes all of the contributions presented in the chapters, synthesizes all the findings, and projects future goals


Cancer researchers, medical scientists, clinicians, graduate students

Table of Contents

1. General properties of NO/metabolites in human diseases
2. Development of novel NO donors/inhibitors and NO complexes: properties, cell signaling, synergy
3. Pharmcokinetics of NO donors/inhibitors in animal models and toxicities
4. Nitrosation and nitrosylation of proteins and their denitrosylation. Characterization of their modified functions
5. Therapeutic applications of NO donors/inhibitors in non-cancer related human diseases
6. Therapeutic applications of NO donors/inhibitors in various cancers


No. of pages:
© Academic Press 2019
Academic Press
Hardcover ISBN:

About the Editor

Benjamin Bonavida

Dr. Bonavida is internationally renowned by his expertise and various publications in the field of tumor cell sensitization to chemotherapy and in particular the novel role of Nitric Oxide (NO) donors in chemo-sensitization and reversal of drug resistance. He was the first individual to co-organize the first international workshop on NO and Cancer with Dr. Jean-François Jeannin in Paris. Subsequently, they co-organized three additional conferences on the same topic. The last fourth workshop was held in March in Sevilla, Spain with Dr. Muntane, and the proceedings were published in Redox Biology recently. These conferences focus on NO and derivatives in cancer and their therapeutic applications in resistant cancer.

Affiliations and Expertise

Professor, Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, USA

Lucia Morbidelli

Dr. Morbidelli’s experience is within the pharmacology of angiogenesis and microcirculation by means of a plethora of in vitro and in vivo models. Since 1993 she contributed to demonstrate the role of nitric oxide pathway in the process of angiogenesis induced by growth factors and drugs. She published 130 papers and chapters in books on the molecular and cellular aspects of angiogenesis mainly in relation to tumor development and progression. From 2012 to 2015, she was a member of the COST Action BM1005 “European Network on Gaseoustransmitters” taking part to the annual meeting of the network and collaborating/interacting with members of the European Union. In the last years, as founder and partner of a spin-off devoted to the development of NO donors, she is contributing to characterize new NO donors in cardiovascular, cancer and inflammation related disorders.

Affiliations and Expertise

Professor, Department of Life Sciences, University of Siena, Siena, Italy

Ratings and Reviews